Van De Donk N, Parekh S, Li K, Lin Y, Martin T, Han S, Montes De Oca R, Suraneni M, Gormley M, Hodkinson B, Yuan J, Wang F, Kumar A, Yin D, Smirnov D, Patel J, Lendvai N, Madduri D, Zhu J, Koneru M, Patel N, Geng D, Plaks V, Harrison S. P44 | EARLIER USE OF CILTACABTAGENE AUTOLEUCEL IS ASSOCIATED WITH BETTER IMMUNE FITNESS AND STRONGER IMMUNE EFFECTS AS SHOWN BY CORRELATIVE ANALYSIS OF PERIPHERAL BLOOD AND THE BONE MARROW TUMOR MICROENVIRONMENT FROM THE CARTITUDE-4 STUDY. haematol [Internet]. 2026Apr.15 [cited 2026Apr.21];111(s2). Available from: https://haematologica.org/article/view/haematol.2026.s2.14058